(VIANEWS) – Suburban Propane Partners, L.P. (SPH), Nuveen Enhanced Municipal Value Fund (NEV), Astrazeneca (AZN) are the highest dividend yield stocks on this list.

Rank Financial Asset Price Change Forward Dividend Yield Updated (EST)
1 Suburban Propane Partners, L.P. (SPH) 15.84 1.08% 7.77% 2021-07-10 02:13:10
2 Nuveen Enhanced Municipal Value Fund (NEV) 17.29 1.53% 4.32% 2021-07-09 19:14:06
3 Astrazeneca (AZN) 60.50 1.46% 2.34% 2021-07-12 15:36:06
4 Rand Capital Corporation (RAND) 17.89 -4.74% 2.33% 2021-07-11 14:45:25

A little less 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. Suburban Propane Partners, L.P. (SPH) – Dividend Yield: 7.77%

Suburban Propane Partners, L.P., through its subsidiaries, engages in the retail marketing and distribution of propane, fuel oil, and refined fuels. The company operates in four segments: Propane, Fuel Oil and Refined Fuels, Natural Gas and Electricity, and All Other. The Propane segment is involved in the retail distribution of propane to residential, commercial, industrial, and agricultural customers, as well as in the wholesale distribution to industrial end users. It offers propane primarily for space heating, water heating, cooking, and clothes drying in the residential and commercial markets; for use as a motor fuel in internal combustion engines to power over-the-road vehicles, forklifts, and stationary engines, as well as to fire furnaces, as a cutting gas to the industrial customers, and in other process applications; and for tobacco curing, crop drying, poultry brooding, and weed control in the agricultural markets. The Fuel Oil and Refined Fuels segment engages in the retail distribution of fuel oil, diesel, kerosene, and gasoline to residential and commercial customers for use primarily as a source of heat in homes and buildings. The Natural Gas and Electricity segment markets natural gas and electricity to residential and commercial customers in the deregulated energy markets in New York and Pennsylvania. The All Other segment sells, installs, and services a range of home comfort equipment, including whole-house heating products, air cleaners, humidifiers, and space heaters. As of September 26, 2020, the company served approximately 1.0 million residential, commercial, industrial, and agricultural customers through 700 locations in 41 states primarily in the east and west coast regions of the United States, as well as portions of the midwest region of the United States and Alaska. Suburban Energy Services Group LLC serves as a general partner of Suburban Propane Partners, L.P. The company was founded in 1945 and is headquartered in Whippany, New Jersey.

Volume

Today’s last reported volume for Suburban Propane Partners, L.P. is 241166, 32.5% below its average volume of 357272.

Suburban Propane Partners, L.P.’s last close was $14.78, 18.7% below its 52-week high of $18.18.

The company’s growth estimates for the current quarter and the next is a negative 68% and a negative 7.6%, respectively.

Suburban Propane Partners, L.P.’s Revenue

Year-on-year quarterly revenue growth grew by 34%, now sitting on 1.22B for the twelve trailing months.

Suburban Propane Partners, L.P.’s Stock Yearly Top and Bottom Value

Suburban Propane Partners, L.P.’s stock is valued at $15.84 at 00:15 EST, way under its 52-week high of $18.18 and way higher than its 52-week low of $12.50.

Suburban Propane Partners, L.P.’s Moving Average

Suburban Propane Partners, L.P.’s worth is higher than its 50-day moving average of $15.21 and higher than its 200-day moving average of $15.05.

More news about Suburban Propane Partners, L.P..

2. Nuveen Enhanced Municipal Value Fund (NEV) – Dividend Yield: 4.32%

Nuveen Enhanced Municipal Value Fund is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of the United States. The fund invests in undervalued municipal securities and other related investments the income from which is exempt from regular federal income taxes. It seeks to invest in investment grade securities with an average maturity of around 23.00 years. The fund employs fundamental analysis with a focus on bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against Standard & Poor's (S&P) National Municipal Bond Index. Nuveen Dividend Advantage Municipal Fund 3 was formed on July 27, 2009 and is domiciled in the United States.

Volume

Today’s last reported volume for Nuveen Enhanced Municipal Value Fund is 25486, 37.77% below its average volume of 40955.

Nuveen Enhanced Municipal Value Fund’s last close was $16.27, 7.82% below its 52-week high of $17.65.

Nuveen Enhanced Municipal Value Fund’s Stock Yearly Top and Bottom Value

Nuveen Enhanced Municipal Value Fund’s stock is valued at $17.29 at 00:15 EST, under its 52-week high of $17.65 and way above its 52-week low of $14.15.

Nuveen Enhanced Municipal Value Fund’s Moving Average

Nuveen Enhanced Municipal Value Fund’s value is higher than its 50-day moving average of $16.60 and higher than its 200-day moving average of $16.34.

More news about Nuveen Enhanced Municipal Value Fund.

3. Astrazeneca (AZN) – Dividend Yield: 2.34%

AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR/Komboglyze, Onglyza, Qtern, Symlin, Xigduo/Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Tudorza/Eklira, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalen and Synagis for infection diseases; Movantik/Moventig, Seroquel IR/Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.

Volume

Today’s last reported volume for Astrazeneca is 10018600, 28.38% above its average volume of 7803730.

Astrazeneca’s last close was $59.63, 8.18% below its 52-week high of $64.94.

Astrazeneca’s Sales

Astrazeneca’s sales growth is 17% for the present quarter and 27.3% for the next.

Astrazeneca’s Revenue

Year-on-year quarterly revenue growth grew by 15.2%, now sitting on 27.58B for the twelve trailing months.

Astrazeneca’s Stock Yearly Top and Bottom Value

Astrazeneca’s stock is valued at $60.50 at 00:15 EST, below its 52-week high of $64.94 and way above its 52-week low of $46.48.

Astrazeneca’s Moving Average

Astrazeneca’s value is higher than its 50-day moving average of $58.25 and way higher than its 200-day moving average of $52.81.

More news about Astrazeneca.

4. Rand Capital Corporation (RAND) – Dividend Yield: 2.33%

Rand Capital Corporation is a business development company and regulated investment company specializing in private equity investments. The firm prefers to make investments through equity or debt instruments in lower middle market and in small to medium-sized privately held companies. It generally lends to more mature companies. The firm does not prefer to invest in real estate sector. It invests in companies that are engaged in the exploitation of new or unique products, technologies, or services. The firm invests in healthcare, consumer products, manufacturing, software, and professional services. It seeks to invest in companies based in the Western and Upstate New York region and its surrounding states with focus on Buffalo and Niagara region. The firm may invest in region within three to five hour drives from Western New York including Canada. It typically invests between $0.5 million and $1.5 million and the total investment in rounds is between $1 million and $5 million. The firm seeks to invest up to maximum of $3 million total per company as part of follow-on investments. It invest in startups and companies having annual revenue up to $10 million. It invest companies having EBITDA up to $5 million. The firm Follow-on investment(s) up to a targeted maximum of $2 million to $3 million total per company. The firm frequently participate three investment round. The firm seeks to be a lead investor in companies within its geographical area and participates in syndicate/co-invest with other investors outside it. It prefers to invest in businesses that are unique or possess proprietary right. The firm prefers to be a minority investor and seeks to take a Board seat in its portfolio companies. It typically holds its investments for a period of five to seven years. Rand Capital Corporation was founded in 1969 and is based in Buffalo, New York.

Volume

Today’s last reported volume for Rand Capital Corporation is 12771, 121.11% above its average volume of 5776.

Rand Capital Corporation’s last close was $18.28, 32.25% below its 52-week high of $26.98.

Rand Capital Corporation’s Revenue

Year-on-year quarterly revenue growth grew by 59.9%, now sitting on 3.48M for the twelve trailing months.

Rand Capital Corporation’s Stock Yearly Top and Bottom Value

Rand Capital Corporation’s stock is valued at $17.89 at 00:15 EST, way below its 52-week high of $26.98 and way above its 52-week low of $10.36.

Rand Capital Corporation’s Moving Average

Rand Capital Corporation’s value is above its 50-day moving average of $17.86 and higher than its 200-day moving average of $17.32.

More news about Rand Capital Corporation.

LEAVE A REPLY

Please enter your comment!
Please enter your name here